Antiparasitics are a group of drugs used to treat illnesses caused by parasites like nematodes, cestodes, trematodes, and infectious protozoa.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V79821 | Antileishmanial agent-21 | Antileishmanial agent-21 (compound 4e) is an antileishmanial agent that targets the Leishmania pteridine reductase 1 (Lm-PTR1). | ||
V54045 | Antileishmanial agent-23 | 745033-86-7 | Antileishmanial agent-23 (compound G1/9) is a potent and specific trypanothione reductase (TR) inhibitor (antagonist) with IC50 of 2.24 ± 0.52 μM. | |
V78023 | Antileishmanial agent-24 | Antileishmanial agent-24 (compound 33) is an antileishmanial drug with IC50 of 5.39 μM against amastigotes. | ||
V79586 | Antileishmanial agent-25 | Antileishmanial agent-25 (compound 24) has selective antileishmanial activity against intracellular anurans, with IC50 in the range of 6.63 μM. | ||
V76291 | Antileishmanial agent-4 | 2922333-23-9 | Antileishmanial agent-4 is a ribonucleoside analog used as an anti-kala-azar agent. | |
V76292 | Antileishmanial agent-5 | 2922333-29-5 | Antileishmanial agent-4 is a ribonucleoside analog that works as an antileishmanial agent. | |
V38954 | Antimalarial agent 1 | 84176-65-8 | Antimalarial agent 1 is a potent antimalarial agent. | |
V34839 | Antimalarial agent 17 | 508187-76-6 | Antimalarial agent 17 is an antimalarial agent that also works as a herbicide. | |
V78024 | Antimalarial agent 18 | Antimalarial agent 18 is a potent antimalarial agent that is electronic, lipophilic, and ferrophobic. | ||
V54080 | Antimalarial agent 19 | 2897630-89-4 | Antimalarial agent 19 (compound 6e) is an antimalarial agent. | |
V54049 | Antimalarial agent 2 | 2829950-49-2 | Antimalarial agent 2 is a new orally bioactive antimalarial drug with rapid killing effect in vitro. | |
V34838 | Antimalarial agent 20 | 1422207-75-7 | Antimalarial agent 20 (Compound 49c) is an antimalarial agent with IC50 of 0.6 nM against the NF54 parasitic strain of P. falciparum in the NF54 protein assay. | |
V79093 | Antimalarial agent 23 | Antimalarial agent 23 is an antimalarial benzimidazole with IC50s of 0.08 μM and 0.10 μM for PfNF54 and PfK1 respectively. | ||
V54060 | Antimalarial agent 24 | 2299199-54-3 | Antimalarial agent 24 (Compound 7) is an in vitro antimalarial agent. | |
V34837 | Antimalarial agent 25 | 2944456-41-9 | Antimalarial agent 25 is an orally bioavailable 1,4-naphthoquinone analogue with antimalarial activity. | |
V34836 | Antimalarial agent 26 | 2299199-56-5 | Antimalarial agent 26 is an orally bioavailable 1,4-naphthoquinone analogue with antimalarial activity. | |
V78025 | Antimalarial agent 27 | Antimalarial agent 27 (compound 11a) is an antimalarial drug that effectively targets Plasmodium falciparum (IC50=0.37 μM). | ||
V78026 | Antimalarial agent 28 | Antimalarial agent 28 (Compound 2i) is an antimalarial agent. | ||
V54109 | Antimalarial agent 29 | 2821078-81-1 | Antimalarial agent 29 (compound 16) is an antimalarial agent with EC500 of 5.2 μM against liver-stage parasites of Plasmodium berghei. | |
V78027 | Antimalarial agent 3 | Antimalarial agent 3 shows nanomolar antimalarial activity (IC50 = 0.035 μM) and has a very high selectivity index against mammalian cells. |